Unlike antipsychotic medications that globally reduce dopaminergic signaling, GLP-1 activation selectively dampens reward-driven dopamine spikes while preserving baseline function
For clinicians, staying informed about evolving regulations will be essential over the next several years
Even if the number on the scale hasnt yet changed as much as youd hoped, you may notice other early signs of progress, such as feeling fuller sooner, experiencing fewer cravings, eating smaller portions, or thinking less about food
It comes down to your goals
The dual agonism enhances both weight reduction and metabolic insulin response
A review of potential antibacterial activities of nisin against Listeria monocytogenes: the combined use of nisin shows more advantages than single use